Annual ROE
289.46%
+200.40%+225.02%
December 1, 2023
Summary
- As of February 8, 2025, KAPA annual return on equity is 289.46%, with the most recent change of +200.40% (+225.02%) on December 1, 2023.
- During the last 3 years, KAPA annual ROE has fallen by -17.25% (-5.62%).
- KAPA annual ROE is now -5.62% below its all-time high of 306.71%, reached on December 1, 2020.
Performance
KAPA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-1215.52%
-1492.88%-538.25%
September 30, 2024
Summary
- As of February 8, 2025, KAPA quarterly return on equity is -1215.52%, with the most recent change of -1492.88% (-538.25%) on September 30, 2024.
- Over the past year, KAPA quarterly ROE has dropped by -1397.86% (-766.62%).
- KAPA quarterly ROE is now -538.25% below its all-time high of 277.36%, reached on June 1, 2024.
Performance
KAPA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KAPA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +225.0% | -766.6% |
| 3 y3 years | -5.6% | - |
| 5 y5 years | -5.6% | - |
KAPA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +225.0% | -538.3% | at low |
| 5 y | 5-year | -5.6% | +225.0% | -538.3% | at low |
| alltime | all time | -5.6% | +225.0% | -538.3% | at low |
Kairos Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -1215.52%(-538.2%) |
| Jun 2024 | - | 277.36%(+24.4%) |
| Mar 2024 | - | 222.92%(+22.3%) |
| Dec 2023 | 289.46% | 182.34%(+131.9%) |
| Sep 2023 | - | 78.62%(+31.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 59.93%(-21.9%) |
| Mar 2023 | - | 76.76%(-13.8%) |
| Dec 2022 | 89.06%(-51.5%) | 89.06% |
| Dec 2021 | 183.80%(-40.1%) | - |
| Dec 2020 | 306.71% | - |
FAQ
- What is Kairos Pharma annual return on equity?
- What is the all time high annual ROE for Kairos Pharma?
- What is Kairos Pharma annual ROE year-on-year change?
- What is Kairos Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Kairos Pharma?
- What is Kairos Pharma quarterly ROE year-on-year change?
What is Kairos Pharma annual return on equity?
The current annual ROE of KAPA is 289.46%
What is the all time high annual ROE for Kairos Pharma?
Kairos Pharma all-time high annual return on equity is 306.71%
What is Kairos Pharma annual ROE year-on-year change?
Over the past year, KAPA annual return on equity has changed by +200.40% (+225.02%)
What is Kairos Pharma quarterly return on equity?
The current quarterly ROE of KAPA is -1215.52%
What is the all time high quarterly ROE for Kairos Pharma?
Kairos Pharma all-time high quarterly return on equity is 277.36%
What is Kairos Pharma quarterly ROE year-on-year change?
Over the past year, KAPA quarterly return on equity has changed by -1397.86% (-766.62%)